These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Inflammation may be a bridge connecting hypertension and atherosclerosis. Li JJ; Chen JL Med Hypotheses; 2005; 64(5):925-9. PubMed ID: 15780486 [TBL] [Abstract][Full Text] [Related]
5. Inflammation in atherosclerosis and psoriasis: common pathogenic mechanisms and the potential for an integrated treatment approach. Späh F Br J Dermatol; 2008 Aug; 159 Suppl 2():10-7. PubMed ID: 18700910 [TBL] [Abstract][Full Text] [Related]
6. [The role of infection and inflammation in the pathogenesis of atherosclerosis]. Jaber J; Murín J; Kinová S; Gavorník P; Ghanem Wisam MA; Radman A; Gharaibeh A; Richter P Vnitr Lek; 2002 Jul; 48(7):657-66. PubMed ID: 12197410 [TBL] [Abstract][Full Text] [Related]
7. [Immune factors in atherosclerosis]. Pasqui AL; Bova G; Maffei S; Auteri A Ann Ital Med Int; 2005; 20(2):81-9. PubMed ID: 16052840 [TBL] [Abstract][Full Text] [Related]
8. Renin-angiotensin system and atherothrombotic disease: from genes to treatment. Jacoby DS; Rader DJ Arch Intern Med; 2003 May; 163(10):1155-64. PubMed ID: 12767951 [TBL] [Abstract][Full Text] [Related]
9. [Unstable atheromatous plaque. Physiopathology and therapeutic approach to coronary insufficiency]. Berkenboom G Rev Med Brux; 2001 Dec; 22(6):497-502. PubMed ID: 11811045 [TBL] [Abstract][Full Text] [Related]
11. Antibodies to oxidized low density lipoprotein: epidemiological studies and potential clinical applications in cardiovascular disease. Gounopoulos P; Merki E; Hansen LF; Choi SH; Tsimikas S Minerva Cardioangiol; 2007 Dec; 55(6):821-37. PubMed ID: 18091649 [TBL] [Abstract][Full Text] [Related]
12. Angiotensin II and inflammation: the effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockade. Dandona P; Dhindsa S; Ghanim H; Chaudhuri A J Hum Hypertens; 2007 Jan; 21(1):20-7. PubMed ID: 17096009 [TBL] [Abstract][Full Text] [Related]
13. Tracing the origins of postoperative atrial fibrillation: the concept of oxidative stress-mediated myocardial injury phenomenon. Elahi MM; Flatman S; Matata BM Eur J Cardiovasc Prev Rehabil; 2008 Dec; 15(6):735-41. PubMed ID: 19020458 [TBL] [Abstract][Full Text] [Related]
14. Role of oxidative modifications in atherosclerosis. Stocker R; Keaney JF Physiol Rev; 2004 Oct; 84(4):1381-478. PubMed ID: 15383655 [TBL] [Abstract][Full Text] [Related]
15. The role of inflammation in atherothrombosis: current and future strategies of medical treatment. Geisler T; Bhatt DL Med Sci Monit; 2004 Dec; 10(12):RA308-16. PubMed ID: 15567994 [TBL] [Abstract][Full Text] [Related]
16. Angiotensin II as a pro-inflammatory mediator. Phillips MI; Kagiyama S Curr Opin Investig Drugs; 2002 Apr; 3(4):569-77. PubMed ID: 12090726 [TBL] [Abstract][Full Text] [Related]
17. Therapeutic strategies by modulating oxygen stress in cancer and inflammation. Fang J; Seki T; Maeda H Adv Drug Deliv Rev; 2009 Apr; 61(4):290-302. PubMed ID: 19249331 [TBL] [Abstract][Full Text] [Related]
18. Role of oxidative stress in angiotensin-II mediated contraction of human conduit arteries in patients with cardiovascular disease. Püntmann VO; Hussain MB; Mayr M; Xu Q; Singer DR Vascul Pharmacol; 2005 Oct; 43(4):277-82. PubMed ID: 16243586 [TBL] [Abstract][Full Text] [Related]
19. Inflammation and atherosclerosis. Steffens S; Mach F Herz; 2004 Dec; 29(8):741-8. PubMed ID: 15599670 [TBL] [Abstract][Full Text] [Related]
20. Multifunctional roles of macrophages in the development and progression of atherosclerosis in humans and experimental animals. Takahashi K; Takeya M; Sakashita N Med Electron Microsc; 2002 Dec; 35(4):179-203. PubMed ID: 12658354 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]